Approved indications for idelalisib include relapsed chronic lymphocytic leukemia, small lymphocytic lymphoma, and follicular B-cell non-Hodgkin lymphoma.
Pharmacists play a critical role in treating patients with breast cancer and can help address their social determinant of health challenges.
Multiple state and federal laws since the COVID-19 pandemic highlight the growing role of technicians
Patients can sometimes develop Guillain-Barre syndrome after having a recent respiratory illness or digestive tract infection and, in rare cases, after receiving certain vaccines.
Alec Smith Insulin Affordability Act provides citizens with a long-term solution to diabetes expenditures.
This review explores cytopenia after CAR T-cell therapy, including its risk stratification and management with growth factors, thrombopoietin-receptor agonists, and hematopoietic stem cell boosts.
The value of a patient-first approach and telehealth for addressing the complex health coordination needs of those with these pulmonary conditions has never been more critical.
Sophie Jabban discusses research presented at the SGO Annual Meeting highlighting significant disparities in MRI access for patients with cervical cancer receiving chemoradiation, with delays linked to both race and insurance status, underscoring systemic barriers that may impact timely treatment.
Dosing recommendations for patients requiring ECMO support are unlikely to be supported by high-quality evidence, but are usually extrapolated from the physicochemical characteristics of individual drugs in conjunction with data from pharmacokinetic studies and case reports.
Sarah Rockwell, PharmD, BCOP, and Ke Ning, MD, share their concluding remarks, reflecting on the current landscape and expressing their aspirations for addressing remaining unmet needs.
From countless hours of studying to participating in pharmacy organizations to volunteering in the community, it’s no surprise that student pharmacists often struggle to find balance as a well-rounded student.
The authors determined that 40 patients (74.1%) converted from chronic to episodic migraine.
Myasthenia gravis is a chronic autoimmune disease that causes muscle weakness and fatigue, with 4 main treatment options available.
The framework includes 6 domains designed to immediately empower students in community pharmacies.
Precision dosing technology uses multiple patient-specific factors to individualize medication doses, helping clinicians reduce medication errors that lead to adverse events.
The updated recommendations include CGRP inhibitors as a first-line treatment option for chronic and episodic migraine prevention.
Although pharmacotherapy is considered for the treatment of insomnia, medication should not be the sole treatment for individuals diagnosed with insomnia.
Ginger Blackmon, PharmD, explains how NCODA’s Positive Quality Interventions (PQIs) help improve oncology care by guiding best practices, supporting teamwork, and streamlining workflows.
Students may be hesitant to discuss migraines, which can lead to absences, difficulties in personal life, financial burdens, and poor mental health.
Pediatric guidelines suggest 10 days of therapy for community-acquired pneumonia, but recent data support shortening therapy duration.
FDA approvals of vaccines usually take 10 to 15 years, but the pandemic necessitates emergency action.
Motivational Interviewing is a collaborative conversation style that can empower patients to stay the course and achieve better outcomes.
Most pharmacists and technicians are unaware of resources that aid in communication.
Oncology pharmacists are as diverse as the cancers they manage and have key roles in the following areas of the cancer care continuum.
With respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have focused on passive immunity
A shortage of pharmacists led to a call for pharmacy education in Alaska that echoed across the state.
Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
When used correctly, weight-loss medications, such as glucagon-like peptide-1 (GLP-1) medications, can be a tool to help reduce costs and provide clinical results.
Cardioprotective antihyperglycemic agents are underutilized for inpatient care in heart failure patients. Lack of use can lead to preventable patient deaths and hospital readmissions.